FIELD: medicine.
SUBSTANCE: invention describes a method for evaluating the clinical effectiveness in lipidemia by pre- and post-therapeutic blood serum analysis wherein the assay is preceded by three blood serum freezing and thawing procedures for 20 minutes and 10 minutes respectively followed by evaluation of apolipoprotein B, lipopolyprotein (a), their relation, total cholesterol and if observing increase of the apolipoprotein B to lipopolyprotein (a) relation by 50% and more and decrease of total cholesterol by 30% and more as compared with the initial level, the lipidemia treatment is stated to be effective. The use of the presented method provides higher accuracy of evaluating the clinical effectiveness in lipidemia.
EFFECT: method is simple to implement and interpret results.
1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR ASSESSING PROGRESSION OF ATHEROGENICITY IN ISCHEMIC HEART DISEASE | 2013 |
|
RU2521322C1 |
METHOD FOR PREDICTION OF CLINICAL COURSE OF LIPIDEMIA | 2013 |
|
RU2517054C1 |
DIAGNOSTIC TECHNIQUE FOR LIPIDEMIA | 2011 |
|
RU2476888C1 |
METHOD FOR PREDICTION OF CLINICAL COURSE OF ISCHEMIC HEART DISEASE | 2012 |
|
RU2520755C1 |
METHOD FOR PREDICTION OF CLINICAL COURSE OF ISCHEMIC HEART DISEASE | 2012 |
|
RU2507518C1 |
METHOD FOR ASSESSING THE EFFECTIVENESS OF THE TREATMENT OF LIPIDEMIA | 2019 |
|
RU2694534C1 |
METHOD FOR DIAGNOSING LIPIDEMIA | 2019 |
|
RU2694531C1 |
METHOD OF PREDICTING COURSE OF ISCHEMIC HEART DISEASE | 2011 |
|
RU2470294C1 |
DIAGNOSTIC TECHNIQUE FOR EARLY AND LATE STAGES OF LIPIDEMIA | 2019 |
|
RU2694538C1 |
METHOD FOR PREDICTION OF CLINICAL COURSE OF LIPIDEMIA | 2019 |
|
RU2714689C1 |
Authors
Dates
2012-09-27—Published
2011-08-09—Filed